Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
Completed · Phase 4 · Has a placebo group
Conditions studied: Pain
In brief
The purpose of this study is to determine if the infusion of the local anesthetic ropivacaine (a numbing medicine) and the non-steroidal anti-inflammatory drug ketorolac (a pain killer similar to ibuprofen) through a catheter placed along the cesarean delivery incision, will reduce the pain experienced after cesarean section and need for narcotic pain medicine.
Key facts
- Study ID
- NCT02829944
- Run by
- Duke University
- People needed
- 84
- Starts
- 2016-11-01
- Expected to finish
- 2019-09-01
- Last updated by the study team
- 2020-03-06
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- American Society of Anesthesiology (ASA) class 1,2, and 3
- English speaking women at a gestational age > 37 weeks
- scheduled for cesarean delivery under spinal or combined spinal epidural anesthesia
You may not qualify if…
- BMI > 50 kg/m2
- history of intravenous drug or opioid abuse
- previous history of chronic pain syndrome
- history of opioid use in the past week
- allergy or contraindication to any of the study medications
- non-English speaking
Where it is running
- Duke University Hospital — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.